Literature DB >> 7970950

Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period.

M Gordon1, H D Davies, R Gold.   

Abstract

To characterize the morbidity of pertussis in Canada, we did a retrospective review of all children with laboratory-confirmed pertussis seen at the Hospital for Sick Children, Toronto, between 1980 and 1990. A total of 975 patients were identified, of which 223 (23%) were admitted to hospital. The peak incidence of disease was observed in the fall. The incidence of disease did not vary with gender. Only 41% of children admitted had the classical symptoms of pertussis (paroxysmal cough and whoop). Compared with children older than 6 months of age, children younger than 6 months of age were more likely to be hospitalized, tended to be hospitalized longer, were less likely to be age-appropriately vaccinated and were more likely to require intensive care unit monitoring. Seventeen (8%) of 223 children required intensive care unit monitoring, and 12 of these children required mechanical ventilation therapy, for a duration of 3.5 +/- 0.6 days (mean +/- SD). One (0.1%) patient with secondary bacterial pneumonia died. This hospital-based study indicates that pertussis continues to be a cause of serious illness in children, particularly those younger than 6 months of age.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970950     DOI: 10.1097/00006454-199407000-00007

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Economic evaluation of a new acellular vaccine for pertussis in Canada.

Authors:  M Iskedjian; T R Einarson; B J O'Brien; J G De Serres; R Gold; I M Gemmill; N Milkovich; A Rosner
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Pertussis is increasing in unimmunized infants: is a change in policy needed?

Authors:  S Ranganathan; R Tasker; R Booy; P Habibi; S Nadel; J Britto
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Authors:  Qi Zhang; Huizhen Zheng; Meizhen Liu; Ke Han; Jun Shu; Chenggang Wu; Ning Xu; Qiushui He; Huiming Luo
Journal:  BMC Infect Dis       Date:  2012-06-20       Impact factor: 3.090

5.  Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.

Authors:  Sylvia Becker-Dreps; Anne M Butler; Leah J McGrath; Kim A Boggess; David J Weber; Dongmei Li; Michael G Hudgens; J Bradley Layton
Journal:  Am J Prev Med       Date:  2018-06-14       Impact factor: 5.043

6.  Clinical and laboratory features of pertussis in hospitalized infants with confirmed versus probable pertussis cases.

Authors:  J Shojaei; Mj Saffar; A Hashemi; Gr Ghorbani; Ms Rezai; S Shahmohammadi
Journal:  Ann Med Health Sci Res       Date:  2014-11

7.  [Clinical, laboratorial and radiographic predictors of Bordetella pertussis infection].

Authors:  Camila Vieira Bellettini; Andressa Welter de Oliveira; Cintia Tusset; Ludmila Fiorenzano Baethgen; Sérgio Luís Amantéa; Fabrizio Motta; Aline Gasparotto; Huander Felipe Andreolla; Alessandro C Pasqualotto
Journal:  Rev Paul Pediatr       Date:  2014-12

8.  Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.

Authors:  Lucy A McNamara; Tami Skoff; Amanda Faulkner; Lisa Miller; Kathy Kudish; Cynthia Kenyon; Marisa Bargsten; Shelley Zansky; Amy D Sullivan; Stacey Martin; Elizabeth Briere
Journal:  Clin Infect Dis       Date:  2017-09-01       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.